A best evidence topic was written according to a structured protocol. The question addressed was: in patients undergoing oesophagectomy for oesophageal malignancy, is low serum albumin associated with postoperative complications? Altogether, 87 papers were found using the reported search, of which 16 demonstrated the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. This paper includes 2 level 2 papers, 12 level 3 papers and 2 level 4 papers. All the papers compared either all or some of the following postoperative complications: mortality, morbidity, anastomotic leak, respiratory and non-respiratory complications, and length of hospital stay. Eleven of the 16 papers found an association between low serum albumin and postoperative complications. Of these, one study showed that low serum albumin combined with low fibrinogen levels (FA score) was predictive of postoperative recurrence of oesophageal cancer. Another study showed that when combined with white cell count and C-reactive protein (CRP, NUn score), serum albumin had a high diagnostic accuracy for major complications after postoperative day 3. The largest study compared the in-hospital mortality in 7227 patients who underwent oesophageal surgery for malignancy. The percentage of in-hospital mortality was associated with low serum albumin (<15.0 vs >35.0 g/l, 21.0 vs 11.3%, P <0.001). Five of the 16 papers found no significant association between low serum albumin and postoperative complications. Of these papers, one showed that low serum albumin was not an independent risk factor, while four others found no association between low serum albumin with respiratory complications, anastomotic leak and postoperative mortality. Instead, these studies found other factors responsible for postoperative complications such as: CRP, smoking, disease duration, malnutrition and low T-cell levels. Taken together, while low serum albumin is associated with postoperative complications, opinion regarding the prognostic value of low serum albumin and nutritional support remains conflicted. Because of the confounding factors encountered in these studies, the clinician should consider the finding of low serum albumin in patients, together with disease and surgical factors to provide optimal care for these patients.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] . 
THREE-PART QUESTION

CLINICAL SCENARIO
You are running a preoperative assessment clinic and see a middle-aged male with T1N0M0 oesophageal cancer. His routine investigations were unremarkable except for a low serum albumin (<4.0 g/dl). You have recently read reports that low serum albumin may lead to postoperative complications. To provide optimal perioperative management, you turn to the literature and review the best evidence available. Morbidity and mortality Patients with albumin <20 g/l were more likely to develop complications than those with albumin >20 g/l (54 vs 28%, respectively, P <0.011)
SEARCH STRATEGY
Patients with albumin <20 g/l had higher rates of ARDS (22 vs 5%, P <0.001), respiratory failure (27 vs 8%, P <0.01), and were more likely to die in the hospital (27 vs 6%, P <0.001) than those with albumin >20 g/l 
Continued
RESULTS
Matsuda et al. [2] examined the between serum fibrinogen and albumin (FA) score with postoperative disease-free survival.
Patients with low serum albumin (<4.0 g/dl) and fibrinogen (<350 mg/dl), and thus a higher FA score, had a higher incidence of cancer recurrence following uni-and multivariate analysis.
Yoshida et al. [3] compared postoperative complications and found no significant predictive relationship between low preoperative serum albumin (<40 g/l) and postoperative pulmonary complications.
Noble et al. [4] examined major complications and anastomotic leak in 258 patients undergoing oesophagogastric resection for high-grade dysplasia. They found a significant association between low serum albumin and major complications on postoperative days 3 and 7, and anastomotic leak. Furthermore, when albumin was combined with C-reactive protein (CRP) and white cell count (WCC) to create a NUn score, they found that a score >10 was predictive of an anastomotic leak and death on postoperative day 4. Poziomyck et al [5] examined mortality in patients who developed postoperative complications following foregut surgery. Lower serum albumin levels were associated with mortality and longer hospital stay.
Shiozaki et al. [6] analysed respiratory complications in patients who underwent oesophagectomy. Serum albumin levels were not significantly different between patients with or without postoperative respiratory complications.
Khan et al. [7] compared postoperative 12-month mortality in patients who underwent subtotal oesophagectomy for malignant disease. Patients who were alive after 12 months had higher preoperative serum albumin levels compared with those who did not.
Marin et al. [8] reviewed postoperative outcomes in patients who underwent major or minor/palliative oesophageal surgery for malignant disease. Patients with higher serum albumin levels (>3.5 g/dl) had less postoperative complications. In a subset of patients undergoing minor surgery (gastrostomy or jejunostomy), lower serum albumin was associated with mortality and 30-day postoperative survival.
Park et al. [9] performed a retrospective multicentre study in 7227 patients who underwent oesophageal surgery for malignancy. They found a positive association between in-hospital mortality and low postoperative serum albumin levels following multiple logistic regression.
Ryan et al. [10] examined morbidity and mortality in patients who underwent oesophagectomy for malignant disease. Patients with lower serum albumin (<20 g/l) on the first postoperative day were more likely to develop respiratory failure or acute respiratory distress syndrome (ARDS), or to die in the hospital. Multiple regression modelling showed that postoperative day 1 albumin level was independently related to postoperative complications.
Tomimaru et al. [11] compared morbidity and mortality between 762 patients who underwent salvage oesophagectomy with or without prior chemoradiation therapy (CRT). The authors showed that while serum albumin and lymphocyte counts were significantly lower in the salvage group, there was no association between preoperative serum albumin and post-oesophagectomy outcomes.
Kudsk et al. [12] performed a study in 706 patients undergoing elective foregut surgery. Patients with lower serum albumin levels had a higher incidence of postoperative complications, mortality, length of intensive care unit stay, postoperative stay and nil per oral days. Nakamura et al. [13] analysed morbidity and mortality in 55 patients undergoing oesophagectomy with or without prior CRT. They found no statistically significant difference in overall mortality between either groups.
Rentz et al. [14] examined morbidity in 945 patients who underwent transthoracic and transhiatal oesophagectomy. They found an association between low serum albumin (<35 g/dl) and postoperative mortality and morbidity in both surgical types.
Bailey et al. [15] compared mortality and morbidity in a prospective cohort study of 1777 patients who underwent oesophagectomy for malignant and benign disease. They showed that lower preoperative albumin level was an independent risk factor for overall morbidity following multivariate analysis.
Takagi et al. [16] examined the presence of infectious complications in 103 patients who underwent oesophagectomy for thoracic oesophageal cancer. They showed that postoperative day 21 serum albumin level was significantly higher in patients without infectious complications compared with those who had infection.
Nishi et al. [17] analysed anastomotic leak and respiratory complications in 364 patients who underwent oesophagectomy, oesophagogastrectomy, and/or partial gastrectomy, and found that serum albumin levels were not correlated with study outcomes.
CLINICAL BOTTOM LINE
Taken together, several studies reviewed in this paper suggest an association between low serum albumin and postoperative complications. However, there are conflicting opinions regarding the prognostic value of low serum albumin, and thus, the role of nutritional support to optimize these patients preoperatively. One limitation of this study is the narrow focus on serum albumin and postoperative complications. Several confounding factors were encountered in some of these papers. For example, chyle leak would decrease in the number of circulating T-cells and lower serum albumin levels, thus causing postoperative infections that may be mistakenly attributed to lowered serum albumin levels.
Other confounding factors such as preoperative chemoradiotherapy, CRP levels and smoking may contribute to postoperative complications. It is important, in clinical practice, to consider the finding of low serum albumin in the context of the patient as well as, disease and surgical factors to provide optimal care for these patients. In addition, further studies are warranted to determine the role of preoperative nutritional support in this group of patients.
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I read with great interest the best evidence topic by Goh et al. [1] on the relationship between preoperative serum albumin levels and postoperative complications in patients undergoing oesophageal resection for oesophageal malignancies. This is a sensitive group in which malnutrition is caused not only by the metabolic perturbations from the neoplastic disease, but also from dysphagia and alimentary tract dysfunction, further aggravating the situation. Indeed, it has been demonstrated that up to 32% of oesophageal cancer patients being considered for oesophagectomy present with severe weight loss, underlining the fact that they are prone to malnutrition [2] . Given the well-established association between malnourishment and poor surgical outcomes, it seems reasonable that patients scheduled for major surgery, such as oesophagectomy, should undergo formal nutritional assessment, and if necessary nutritional support. Among the various indices used for the evaluation of the nutritional status, hypoalbuminaemia defined as serum albumin level <3.0 g/dl, has been identified as the most valuable predictor of adverse postoperative outcomes, while to date, the only validated assessment method for surgical patients is the NRS-2002, which is based on weight loss, reduced intake and disease severity [3] . It is important to note that nutritional assessment of the surgical patient is not used to "clear" him for surgery, but rather to optimize surgical outcomes in high-risk groups.
When the oesophagectomy candidate is found to be malnourished, the options to proceed with nutritional support include oral supplements, parenteral nutrition (PN) and enteral tube feeding. The potential benefits of the first option are frequently unattainable due to gastrointestinal intolerance, anorexia and non-compliance, while the major drawbacks to preoperative initiation of PN include glycaemic variability, central line complications and the risk of infection. Nevertheless, PN has been found particularly useful for patients undergoing upper gastrointestinal surgery, given that it can be provided for at least 7 days during the preoperative period [3] . A meta-analysis of various nutritional support methods in patients undergoing gastrointestinal surgery demonstrated that enteral nutrition (EN) is advantageous over PN in terms of infectious complications, anastomotic leaks and duration of hospital stay. Moreover, EN is especially beneficial for patients with malnutrition or malignancy [4] . Feeding jejunostomy tubes (JT) inserted percutaneously, endoscopically or laparoscopically can provide the desired route for EN before oesophagectomy or neoadjuvant therapy, although their routine use has been associated with the development of major complications, including reoperation, bowel ischaemia and even death [5] . However, in the malnourished patient undergoing oesophageal resection apart from preoperative support, JT will also provide the postoperative nutritional bridge to oral intake.
Conflict of interest: none declared.
I read with interest the excellent paper from Goh et al. [1] . It comprehensively addressed the question of whether serum albumin acts as a predictor of complications in the postoesophagectomy patient. The authors took into account the important fact that low serum albumin may occur secondary to a number of other possible confounding factors. They also briefly address the fact that little is known about the role of preoperative nutritional support in these patients.
This paper leads to a number of further questions that should be asked. Firstly, is there a difference in the predictive value of albumin if it is low in the preoperative setting, but restored using nutritional support to a normal level postoperatively, compared to the patient with a normal preoperative albumin which becomes low in the postoperative setting? Secondly, is there an ideal time and rate at which to improve a patient's albumin level in order to reduce the chances of further complications? Finally, is there a difference in outcomes between patients who have their albumin restored using parenteral nutrition versus those patients who have this done using enteral nutrition?
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